{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fthe-limbic.simplecast.com%2Fepisodes%2Fcar-t-in-the-real-world-new-indications-b7_iCtYU","width":444,"version":"1.0","type":"rich","title":"CAR T in the real world: New indications","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/625cf068-4381-4a96-971a-7ccc5429c672/cf58bca6-8ebe-4988-9005-de1886804905/thelimbic-mark-black.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/262c6ab5-7010-4b62-aa7d-000d7d2169a7\" height=\"200\" width=\"100%\" title=\"CAR T in the real world: New indications\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this first episode, Dr Maeve O’Reilly, a consultant haematologist at University College Hospital London, takes us through new approvals and indications of CAR T and what to expect next."}